Taipei, June 22 (CNA) Approximately 980,000 tablets of a prescription medicine to treat high blood pressure have been ordered removed from pharmacy shelves, with a full recall to be completed by early August after being found to contain an insufficient amount of a key ingredient, the Food and Drug Administration (FDA) announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open higher
05/29/2023 09:09 AM - Culture
Taiwanese artist's animated film shines at Tokyo art fair
05/28/2023 09:07 PM - Society
One child dead, one missing in separate drowning incidents on east coast
05/28/2023 06:54 PM - Sports
Cheerleaders, VP video speech open Oakland A's Taiwan Day event
05/28/2023 05:39 PM - Society
Temperatures top 39 degrees in Kaohsiung
05/28/2023 05:09 PM